Marsha Fanucci

From 2000 to 2009, Ms. Fanucci served at Millennium Pharmaceuticals in a number of executive leadership positions, including Chief Financial Officer and Senior Vice President of Strategy, Vice President of Finance and Strategy, and Vice President of Corporate Development and Strategy. During her tenure, Ms. Fanucci directly contributed to a series of strategic processes, advanced investment-stage Millennium to profitability and was instrumental in the acquisition by Takeda Pharmaceutical Company in 2008 for $8.8 billion. Previously, Ms. Fanucci was Vice President of Corporate Development and Strategy at Genzyme Corporation and Vice President and Director at Arthur D. Little. Ms. Fanucci serves on the boards of directors of Alnylam Pharmaceuticals and Syros Pharmaceuticals and serves as the chair of the Cyclerion Pharmaceuticals board. Ms. Fanucci received a B.S. in pharmacy from West Virginia University Medical School and an M.B.A. from Northeastern University.